Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels

被引:22
作者
Asselah, T [1 ]
Martinot, M
Cazals-Hatem, D
Boyer, N
Auperin, A
Le Breton, V
Erlinger, S
Degott, C
Valla, D
Marcellin, P
机构
[1] Hop Beaujon, Serv Hepatol, INSERM, U481, F-92110 Clichy, France
[2] Hop Beaujon, Ctr Rech Claude Bernard Hepatites Virales, Clichy, France
[3] Hop Beaujon, Serv Anat Pathol, Clichy, France
关键词
alanine aminotransferase; chronic hepatitis C; genotype; hepatitis C virus; hypervariable region 1; viral quasispecies;
D O I
10.1046/j.1365-2893.2002.00327.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The role of hepatitis C virus (HCV) heterogeneity in the severity of chronic hepatitis C infection remains unclear. Our aim was to study the hypervariable region 1 (HVR1) heterogeneity in patients with chronic hepatitis C infected with genotype 1b or 3 and with normal or abnormal alaninc aminotransferase (ALT). HVR1 quasispecies were assessed by single strand conformational polymorphism (SSCP) in 67 patients with chronic hepatitis C, including 3 5 with persistently normal ALT and 32 with abnormal ALT. Sixty-two patients underwent a liver biopsy. Among the 67 patients, 40 were infected with genotype 1b and 27 with genotype 3. In univariate analysis, low heterogeneity (5 3 bands at SSCP) was significantly associated with normal ALT (P<0.001). milder histological lesions (activity, P=0.02; fibrosis, P=0.04), and at the limit of significance for genotype 1b (P=0.07). In multivariate analysis, low heterogeneity was significantly and independently associated with normal ALT (P=0.09) and genotype 1b (P=0.03). In patients with chronic hepatitis C, a low viral heterogeneity is significantly and independently associated with normal ALT and genotype 1b. These results are consistent with the view that patients with normal ALT have a different immune response against HCV resulting in a low HCV heterogeneity.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 38 条
  • [1] HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV
    ALBERTI, A
    MORSICA, G
    CHEMELLO, L
    CAVALLETTO, D
    NOVENTA, F
    PONTISSO, P
    RUOL, A
    [J]. LANCET, 1992, 340 (8821) : 697 - 698
  • [2] Hepatitis C in asymptomatic blood donors
    Alter, HJ
    ConryCantilena, C
    Melpolder, J
    Tan, D
    VanRaden, M
    Herion, D
    Lau, D
    Hoofnagle, JH
    [J]. HEPATOLOGY, 1997, 26 (03) : S29 - S33
  • [3] [Anonymous], 1997, HEPATOLOGY, V26, pS2
  • [4] Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis
    Benvegnu, LB
    Pontisso, P
    Cavalletto, D
    Noventa, F
    Chemello, L
    Alberti, A
    [J]. HEPATOLOGY, 1997, 25 (01) : 211 - 215
  • [5] Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
    Detmer, J
    Lagier, R
    Flynn, J
    Zayati, C
    Kolberg, J
    Collins, M
    Urdea, M
    SanchezPescador, R
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 901 - 907
  • [6] EASL (European Association for the Study of the Liver), 1999, J HEPATOL S1, V31, P3
  • [7] EVALUATION OF ANTIBODIES TO HEPATITIS-C VIRUS IN A STUDY OF TRANSFUSION-ASSOCIATED HEPATITIS
    ESTEBAN, JI
    GONZALEZ, A
    HERNANDEZ, JM
    VILADOMIU, L
    SANCHEZ, C
    LOPEZTALAVERA, JC
    LUCEA, D
    MARTINVEGA, C
    VIDAL, X
    ESTEBAN, R
    GUARDIA, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (16) : 1107 - 1112
  • [8] Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection
    Hayashi, J
    Kishihara, Y
    Yamaji, K
    Furusyo, N
    Yamamoto, T
    Pae, Y
    Etoh, Y
    Ikematsu, H
    Kashiwagi, S
    [J]. HEPATOLOGY, 1997, 25 (03) : 697 - 701
  • [9] HYPERVARIABLE REGIONS IN THE PUTATIVE GLYCOPROTEIN OF HEPATITIS-C VIRUS
    HIJIKATA, M
    KATO, N
    OOTSUYAMA, Y
    NAKAGAWA, M
    OHKOSHI, S
    SHIMOTOHNO, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (01) : 220 - 228
  • [10] HONDA M, 1994, HEPATOLOGY, V20, P1144, DOI 10.1002/hep.1840200507